Vaxcyte, Inc. PCVX Non-Cash Lease Expense
Non-Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s non-cash lease expense?
- Vaxcyte, Inc. (PCVX) reported non-cash lease expense of $2.91M in Q1 2026.
- How has Vaxcyte, Inc.'s non-cash lease expense changed year-over-year?
- Vaxcyte, Inc.'s non-cash lease expense increased by 51.6% year-over-year, from $1.92M to $2.91M.
- What is the long-term trend for Vaxcyte, Inc.'s non-cash lease expense?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s non-cash lease expense has grown at a 50.3% compound annual growth rate (CAGR), from $1.66M to $8.46M.
- What does non-cash lease expense mean?
- Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.